Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. - Maini, R; Taylor, P; Paleolog, E; Charles, P; Ballara, S; Brennan, F; Feldmann, M (1999)